A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs of efficacy as
Month: April 2022
Recurrent non-invasive breast tumors may not always be related to the primary lesion
More than 10 percent of cases of recurrent ductal carcinoma in situ (DCIS) of the breast were “de novo” tumors
KRAS G12C inhibitor sotorasib may offer long-term clinical benefit in patients with non-small cell lung cancer
Patients with non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitor sotorasib (Lumakras) had a two-year overall survival
NK cells combined with bispecific antibody showed strong response for patients with lymphoma
Researchers from The University of Texas MD Anderson Cancer Center showed that natural killer (NK) cells derived from donated umbilical
New evidence for increased cardiovascular risks from indoor and outdoor air pollution
It has long been suspected that exposure to indoor and outdoor air pollutants may increase an individual’s risk for cardiovascular
Climate change may push the US toward the ‘Goldilocks zone’ for West Nile virus
Michael Keasling of Lakewood, Colorado, was an electrician who loved big trucks, fast cars, and Harley-Davidsons. He’d struggled with diabetes
Healthy eating education improves young adults’ eating habits
A population health survey in Hong Kong revealed that 50% of people aged 15 to 84 were either overweight or
An AI model may predict elevated pancreatic cancer risk using electronic health records
An artificial intelligence (AI) model trained using sequential health information derived from electronic health records identified a subset of individuals
Alzheimer’s brain barrier damage theory could pave way for new treatments
Alzheimer’s Disease could be caused by damage to a protective barrier in the body that allows fatty substances to build
Detroit’s longtime problem with asthma is getting much worse
Shelia Bernard remembers the way asthma made her daughter wheeze, how a cold would turn so bad she’d have to
